Count |
Stain |
Antibodies against cytokeratins |
[70] |
DNA-based strategies |
Sanger sequencing |
PIK3CA and EGFR |
[71] |
Next-generation sequencing |
The complete exome and genome |
[72-74] |
Multiple displacement amplification |
Single nucleotide polymorphism |
[72] |
Comparative array genomic hybridization |
Genomic profiling of CTCs |
[75] |
mRNA-based strategies |
Reverse-transcription PCR |
CK18, CK19, CK20, MUC1, prostate-specific antigen, and carcinoembryonic antigen |
[76] |
Digital PCR |
ATP |
[77] |
RNA sequencing |
Wnt2 |
[78] |
Multicolor RNA in situ hybridization |
Multiple gene targets |
[79] |
Protein-based strategies |
Mass cytometry |
Phosphorylation states |
[80-82] |
CellSearch |
CKs, CD45, and DAPI |
[76] |
Epithelial ImmunoSPOT |
Secreted, shed, or released proteins |
[83] |
High-speed automated digital microscopy |
Antibodies with fluorescent conjugates |
[84] |
Microfluidic technologies |
[85] |
Mass spectrometry approaches |
[82] |